Multi-year healthcare organizational transformations
• Redesigned the go-to-market strategy and forecasted consumer demand for a specialty medical imaging device player based on market opportunity and customer attributes, resulting in a 20% cost reduction ($4M of annual savings)
• Developed detailed business model archetypes and a business case ($750M revenue) for a medical product release. Drove customer/user insights to align value proposition to user needs (via survey-based segmentation and conjoint pricing studies) R&D corporate strategy
• Developed a generative AI strategy and deployment roadmap for clinical data management use cases, estimated to save $30M+ annually for a top 10 global pharmaceutical company
• Analyzed spending in pre-clinical analytical testing and clinical trial support services to help develop an R&D procurement strategy for a global pharmaceutical company, resulting in a 7% reduction in annual spend Product management
• Deployed AI/Automation models in a

• Performed data analyses to identify the gaps in education among the 50 US states on their state Medicaid/CHIP program integrity (PI) measures, and collaborated with policy officials to design and implement 9 oversight activities for various CMS programs
• Curated a list of 30 promising practices, 28 of which were adopted and presented at the annual Medicaid Integrity Institute symposium to guide states with the implementation of their Medicaid/CHIP corrective actions

• Managed and coordinated 12 clinical trials across diverse therapeutic areas, including breast cancer, lung cancer, head and neck cancer, and lymphoma, ensuring adherence to protocol and ICH/GCP, HIPAA, and SOC guidelines.
• Developed and maintained 2 quality improvement processes that recovered over $650,000 in lost revenue from missing billable items, through the setup of a clinical trials management systems (CTMS)

• Crafted and presented 7 compelling proposals at bid defenses, 5 of which were awarded, and orchestrated the seamless day-to-day management of lead drug candidates
• Managed a clinical trial drug pipeline of 142 drug candidates ($50 million revenue), driving successful coordination of team projects and client interactions